M D Clayman
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M D Clayman.
Journal of Clinical Investigation | 1986
M D Clayman; Lauren Michaud; J Brentjens; G. Andres; Nicholas A. Kefalides; Eric G. Neilson
Using a monoclonal anti-tubular basement membrane antibody (alpha TBM-Ab) affinity column, we isolated from collagenase-solubilized human renal tissue (HSRTA) a predominantly 48,000-mol-wt moiety (H3M-1) which is selectively recognized by antisera from two patients with alpha TBM-Ab-associated interstitial nephritis (alpha TBM disease). Whereas both antisera had alpha TBM-Ab titers of 1:64-1:128 by immunofluorescence on tissue sections, their reactivity with H3M-1 in a solid-phase radioimmunoassay was demonstrable at dilutions up to 1:10,000. While these sera displayed some reactivity with pre-column HSRTA, this was markedly less than with H3M-1. HSRTA depleted of H3M-1 by passage over the alpha TBM-Ab affinity column was almost completely depleted of reactivity. Neither pooled normal human sera nor sera from patients with a variety of renal lesions not associated with alpha TBM-Ab (including interstitial nephritis and antiglomerular basement membrane disease) were reactive with H3M-1. Both patient antisera containing alpha TBM-Ab were also highly reactive with R3M-1, the 48,000-mol-wt rabbit glycoprotein antigen of experimental alpha TBM disease. Furthermore, a competitive inhibition radioimmunoassay revealed that alpha TBM-Ab from rodents with experimental alpha TBM disease could inhibit 45-98% of the R3M-1 binding reactivity of patient antisera and 85% of the H3M-1 binding reactivity of patient antisera, thus suggesting paratypic cross-reactivity. We conclude, therefore, that tubular basement membrane target epitopes and their paratypic recognition are highly conserved among mammals.
Journal of Clinical Investigation | 1985
David B. Agus; Richard Mann; Debbie Cohn; Lauren Michaud; Carolyn J. Kelly; M D Clayman; Eric G. Neilson
The protective effect of dietary protein restriction on the development and expression of immune-mediated interstitial nephritis was evaluated in Brown Norway rats with anti-tubular basement membrane disease. In the first series of experiments, pair-fed rats received low protein (LP) (3% casein) or normal protein (NP) (27% casein), normocaloric diets. After 6 wk, each group was immunized with renal tubular antigen in adjuvant to produce anti-tubular basement membrane antibody (alpha TBM-Ab) and tubulointerstitial nephritis. The kidneys harvested from NP rats after four more weeks on the diet had histologically more severe interstitial disease than the LP rats (histologic severity; NP = 3.1 +/- 0.2 vs. LP = 1.1 +/- 0.3; P less than 0.001), and serum creatinine values were concordantly different (NP = 1.34 +/- 0.02 vs. LP = 0.82 +/- 0.03). Titers of alpha TBM-Ab were similar in both groups, while the T cell-mediated immune response, as measured by delayed-type hypersensitivity (DTH), was nonspecifically impaired in LP rats when compared with the NP group. Admixture cotransfers of LP plus NP cells failed to demonstrate active suppression as an explanation for the depressed DTH in LP rats. The therapeutic role of dietary protein restriction was also examined in rats with established alpha TBM disease. In these experiments, rats were first immunized and fed NP diets for 4 wk (histologic severity = 3.0 +/- 0.2; creatinine = 1.78 +/- 0.02), and then were divided into two groups and followed for six more weeks on either LP or NP diets. LP rats, under these conditions, developed less disease than those fed NP diet (histologic severity; NP = 3.2 +/- 0.3 vs. LP = 1.4 +/- 0.2; P less than 0.001), and serum creatinine values were concordantly different (NP = 1.92 +/- 0.05 vs. LP = 0.97 +/- 0.02). Again, the titers of alpha TBM-Ab in both LP and NP groups were similar. These data collectively suggest that LP diet has a protective effect both on the development and extent of tubulointerstitial nephritis that is perhaps, in part, related to the selective abrogation of effector T cell immunity.
International Archives of Allergy and Immunology | 1988
Winston Y. Shih; M D Clayman; Carolyn J. Kelly; William H. Hines; Eric G. Neilson
Antibodies eluted from kidneys by traditional methods of pH shift have been used as reagents in a wide variety of experimental analyses without knowledge of whether their ligand affinity influenced their removal from parenchymal tissue. In the current study we employed two monoclonal antibodies, differing only in their functional affinity (high; K = 2.1 x 10(8)/M and low; K = 6.2 x 10(6)/M) to a common ligand found on the renal basement membrane, to evaluate whether a standard elution technique might selectively facilitate the removal of one antibody over the other. Our findings indicate, however, that the routine methods of elution by pH shift remove both antibodies equally well (41-48%), and without loss of paratypic function. These results provide new evidence that elution by pH shift can produce eluate antibodies which are not biased by preferred affinities.
Archive | 1986
M D Clayman; Carl S. Goldstein; Eric G. Neilson
It is generally agreed that the immune system plays a central role in many forms of renal injury. Hallmark studies of Dixon et al. (1961) emphasized the importance of antibodies and immune complex deposition in glomerular disease processes. A wealth of data have subsequently accumulated which lend support to the concept that humoral immunity is an intrinsic component of many nephritogenic immune responses. The conceptual framework for understanding renal immunology, as a result, has been largely defined in terms of antibody production, renal deposition, and subsequent immune amplification processes.
Proceedings of the National Academy of Sciences of the United States of America | 1992
H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; Eric G. Neilson
Journal of Experimental Medicine | 1985
M D Clayman; Antonio Martinez-Hernandez; Lauren Michaud; Robert Alper; Richard Mann; Nicholas A. Kefalides; Eric G. Neilson
Journal of Immunology | 1984
Eric G. Neilson; E McCafferty; A Feldman; M D Clayman; B Zakheim; R Korngold
Journal of Immunology | 1984
B Zakheim; E McCafferty; S M Phillips; M D Clayman; Eric G. Neilson
Journal of Immunology | 1985
Eric G. Neilson; E McCafferty; Richard Mann; Lauren Michaud; M D Clayman
Journal of Immunology | 1986
Carolyn J. Kelly; R Korngold; Richard Mann; M D Clayman; Thomas P. Haverty; Eric G. Neilson